These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 25374013)

  • 1. Serpin regulation of fibrinolytic system: implications for therapeutic applications in cardiovascular diseases.
    Al-Horani RA
    Cardiovasc Hematol Agents Med Chem; 2014; 12(2):91-125. PubMed ID: 25374013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Role of Fibrinolytic System in Health and Disease.
    Kwaan HC
    Int J Mol Sci; 2022 May; 23(9):. PubMed ID: 35563651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The fibrinolytic system: A new target for treatment of depression with psychedelics.
    Idell RD; Florova G; Komissarov AA; Shetty S; Girard RB; Idell S
    Med Hypotheses; 2017 Mar; 100():46-53. PubMed ID: 28236848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recognition of Plasminogen Activator Inhibitor Type 1 as the Primary Regulator of Fibrinolysis.
    Urano T; Suzuki Y; Iwaki T; Sano H; Honkura N; Castellino FJ
    Curr Drug Targets; 2019; 20(16):1695-1701. PubMed ID: 31309890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SARS-CoV-2 infection results in upregulation of Plasminogen Activator Inhibitor-1 and Neuroserpin in the lungs, and an increase in fibrinolysis inhibitors associated with disease severity.
    Toomer KH; Gerber GF; Zhang Y; Daou L; Tushek M; Hooper JE; Francischetti IMB
    EJHaem; 2023 May; 4(2):324-338. PubMed ID: 37206290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serpins in thrombosis, hemostasis and fibrinolysis.
    Rau JC; Beaulieu LM; Huntington JA; Church FC
    J Thromb Haemost; 2007 Jul; 5 Suppl 1(Suppl 1):102-15. PubMed ID: 17635716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specificity of serine proteinase/serpin complex binding to very-low-density lipoprotein receptor and alpha2-macroglobulin receptor/low-density-lipoprotein-receptor-related protein.
    Kasza A; Petersen HH; Heegaard CW; Oka K; Christensen A; Dubin A; Chan L; Andreasen PA
    Eur J Biochem; 1997 Sep; 248(2):270-81. PubMed ID: 9346278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Releasing the Brakes on the Fibrinolytic System in Pulmonary Emboli: Unique Effects of Plasminogen Activation and α2-Antiplasmin Inactivation.
    Singh S; Houng A; Reed GL
    Circulation; 2017 Mar; 135(11):1011-1020. PubMed ID: 28028005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibrinolysis: the key to new pathogenetic mechanisms.
    Zorio E; Gilabert-Estellés J; España F; Ramón LA; Cosín R; Estellés A
    Curr Med Chem; 2008; 15(9):923-9. PubMed ID: 18473800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serpins, the vasculature, and viral therapeutics.
    Richardson J; Viswanathan K; Lucas A
    Front Biosci; 2006 Jan; 11():1042-56. PubMed ID: 16146796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The pro-urokinase plasminogen-activation system in the presence of serpin-type inhibitors and the urokinase receptor: rescue of activity through reciprocal pro-enzyme activation.
    Behrendt N; List K; Andreasen PA; Danø K
    Biochem J; 2003 Apr; 371(Pt 2):277-87. PubMed ID: 12534347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of PAI-1: a new anti-thrombotic approach.
    Wu Q; Zhao Z
    Curr Drug Targets Cardiovasc Haematol Disord; 2002 Jun; 2(1):27-42. PubMed ID: 12769655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biological control of tissue plasminogen activator-mediated fibrinolysis.
    Rånby M; Brändström A
    Enzyme; 1988; 40(2-3):130-43. PubMed ID: 3139402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroserpin, a thrombolytic serine protease inhibitor (serpin), blocks transplant vasculopathy with associated modification of T-helper cell subsets.
    Munuswamy-Ramanujam G; Dai E; Liu L; Shnabel M; Sun YM; Bartee M; Lomas DA; Lucas AR
    Thromb Haemost; 2010 Mar; 103(3):545-55. PubMed ID: 20135065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of extracellular DNA on plasminogen activation and fibrinolysis.
    Komissarov AA; Florova G; Idell S
    J Biol Chem; 2011 Dec; 286(49):41949-41962. PubMed ID: 21976662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. "Super" SERPINs-A stabilizing force against fibrinolysis in thromboinflammatory conditions.
    Humphreys SJ; Whyte CS; Mutch NJ
    Front Cardiovasc Med; 2023; 10():1146833. PubMed ID: 37153474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elements of the fibrinolytic system.
    Lijnen HR
    Ann N Y Acad Sci; 2001; 936():226-36. PubMed ID: 11460480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms of physiological fibrinolysis.
    Lijnen HR; Collen D
    Baillieres Clin Haematol; 1995 Jun; 8(2):277-90. PubMed ID: 7549063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Matrix metalloproteinases and cellular fibrinolytic activity.
    Lijnen HR
    Biochemistry (Mosc); 2002 Jan; 67(1):92-8. PubMed ID: 11841344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coagulofibrinolytic changes in patients with disseminated intravascular coagulation associated with post-cardiac arrest syndrome--fibrinolytic shutdown and insufficient activation of fibrinolysis lead to organ dysfunction.
    Wada T; Gando S; Mizugaki A; Yanagida Y; Jesmin S; Yokota H; Ieko M
    Thromb Res; 2013 Jul; 132(1):e64-9. PubMed ID: 23726093
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.